Search Publications

Publications

Pubmed ID Author Year Title

15132093

Murray R

2004

PCOS. Uncovering polycystic ovary syndrome.

15136950

Hahn S

2004

[Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].

15138976

Shukunami K

2004

Acute abdomen in a Jehovah's witness with chronic anemia.

15140793

Bacon WL

2004

Progesterone injection and egg production in turkey hens.

15140873

Norman RJ

2004

Improving reproductive performance in overweight/obese women with effective weight management.

15145273

Al-Omari WR

2004

Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome.

15145276

Kilic-Okman T

2004

N-acetyl-cysteine treatment for polycystic ovary syndrome.

15149566

Urman B

2004

Assisted reproduction in the treatment of polycystic ovarian syndrome.

15149567

Pasquali R

2004

Role of changes in dietary habits in polycystic ovary syndrome.

15149568

Cheang KI

2004

Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?

15151470

Wagh A

2004

Treatment of metabolic syndrome.

15151714

Yarali H

2004

Gonadotrophin treatment in patients with polycystic ovary syndrome.

15151718

Chian RC

2004

In-vitro maturation of immature oocytes for infertile women with PCOS.

15153896

Heymann WR

2004

Hyperandrogenism and the skin.

15155816

Yen HW

2004

Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries.

15159300

Zheng W

2004

Population-based case-control study of CYP11A gene polymorphism and breast cancer risk.

15159768

Wright CE

2004

Dietary intake, physical activity, and obesity in women with polycystic ovary syndrome.

15163305

Mueck AO

2004

Hormone therapy after endometrial cancer.

15166126

Revel A

2004

In vitro maturation and fertilization of oocytes from an intact ovary of a surgically treated patient with endometrial carcinoma: case report.

15166128

van Wely M

2004

An economic comparison of a laparoscopic electrocautery strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome.

15169578

Azziz R

2004

PCOS: a diagnostic challenge.

15169580

Yildiz BO

2004

Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome.

15178657

Duleba AJ

2004

Proliferation of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress.

15178661

Panidis D

2004

Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione.

15178663

Amer SA

2004

Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success.

15178665

Vanky E

2004

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.

15178898

Mueck AO

2004

Hormone therapy after endometrial cancer.

15181035

San Mill?n JL

2004

Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.

15181051

Unl?hizarci K

2004

The investigation of insulin resistance in patients with idiopathic hirsutism.

15181052

Azziz R

2004

The prevalence and features of the polycystic ovary syndrome in an unselected population.

15181054

Ganie MA

2004

Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study.

15181063

Guido M

2004

Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.

15181081

Vrb?kov? J

2004

Insulin sensitivity in women with polycystic ovary syndrome.

15181086

Alcoser SY

2004

Association of the (AU)AT-rich element polymorphism in PPP1R3 with hormonal and metabolic features of polycystic ovary syndrome.

15184695

Weiner CL

2004

Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls.

15186884

Erdem CZ

2004

Polycystic ovary syndrome: dynamic contrast-enhanced ovary MR imaging.

15191349

Diamanti-Kandarakis E

2004

The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.

15192061

Legro RS

2004

Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?

15193488

Walch K

2004

A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome.

15197822

Horejsi R

2004

Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women.

15200772

Wu MH

2004

Effects of laparoscopic ovarian drilling on young adult women with polycystic ovarian syndrome.

15202836

Borgia F

2004

Correlation between endocrinological parameters and acne severity in adult women.

15206484

Gerli S

2003

Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.

15209536

Duskov? M

2004

What may be the markers of the male equivalent of polycystic ovary syndrome?

15214247

Barron ML

2004

Proactive management of menstrual cycle abnormalities in young women.

15214709

Kriplani A

2004

Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.

15217995

Mulders AG

2004

Changes in anti-M?llerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility.

15220312

Panidis D

2004

Resistin as a local factor in polycystic ovary syndrome: a novel view of adipo(cyto)kines?

15222920

Palep-Singh M

2004

An observational study of Yasmin in the management of women with polycystic ovary syndrome.

15223049

Kaltsas GA

2004

Secondary forms of polycystic ovary syndrome.

15225184

Saleh AM

2004

Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.

15229206

Ib??ez L

2004

Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.

15232309

Musso C

2004

Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective.

15232482

Al-Fadhli R

2004

Laparoscopic treatment of polycystic ovaries: is its place diminishing?

15233555

Bahceci M

2004

Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.

15235215

Dhindsa G

2004

Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.

15237026

Salamalekis E

2004

Insulin levels, insulin resistance, and leptin levels are not associated with the development of ovarian hyperstimulation syndrome.

15237028

Villa P

2004

Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome.

15237040

Practice Committee of the American Society for Reproductive Medicine.

2004

Current evaluation of amenorrhea.

15237703

Villa P

2004

Which treatment options should be used in adolescents with polycystic ovary syndrome?

15240612

Moran LJ

2004

Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition.

15240646

Phy JL

2004

Insulin and messenger ribonucleic acid expression of insulin receptor isoforms in ovarian follicles from nonhirsute ovulatory women and polycystic ovary syndrome patients.

15242999

van Wely M

2004

Laparoscopic electrocautery of the ovaries versus recombinant FSH in clomiphene citrate-resistant polycystic ovary syndrome. Impact on women's health-related quality of life.

15245382

Linn? Y

2004

Effects of obesity on women's reproduction and complications during pregnancy.

15251831

Iuorno MJ

2002

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.

15254767

Beloosesky R

2004

Induction of polycystic ovary by testosterone in immature female rats: Modulation of apoptosis and attenuation of glucose/insulin ratio.

15255282

Cleemann L

2004

Laparoscopic ovarian drilling as first line of treatment in infertile women with polycystic ovary syndrome.

15255372

Szil?gyi A

2003

Endocrine characteristics of polycystic ovary syndrome (PCOS).

15256506

Nikolaou D

2004

Early ovarian ageing: are women with polycystic ovaries protected?

15257813

Ehrmann DA

2004

Genetic contributions to glucose intolerance in polycystic ovary syndrome.

15257815

Gomel V

2004

Surgical treatment of polycystic ovary syndrome associated with infertility.

15258677

Omar HA

2004

Clinical profiles, occurrence, and management of adolescent patients with HAIR-AN syndrome.

15262192

Lakhani K

2004

Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries.

15262344

Ben-Haroush A

2004

Insulin resistance and metformin in polycystic ovary syndrome.

15262356

Noyan V

2004

The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.

15264005

Prata Lima MF

2004

Effects of melatonin on the ovarian response to pinealectomy or continuous light in female rats: similarity with polycystic ovary syndrome.

15265464

Caballero AE

2004

Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes.

15269926

Seaman HE

2004

Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.

15270785

Glueck CJ

2004

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.

15274286

Doelle GC

2004

The clinical picture of metabolic syndrome. An update on this complex of conditions and risk factors.

15279073

Faloia E

2004

Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome.

15282445

Loverro G

2004

Polycystic ovary syndrome and cardiovascular disease.

15283061

Pauli S

2004

Polycystic ovary syndrome after menopause: a case report.

15284005

Wood JR

2004

The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling.

15284212

Hwang JL

2004

Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.

15284763

Mor E

2004

The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis.

15291743

Diao FY

2004

The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray.

15292290

Guzick DS

2004

Cardiovascular risk in PCOS.

15292291

Orio F Jr

2004

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study.

15292303

Piltonen T

2004

Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome.

15292314

Brettenthaler N

2004

Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome.

15292352

Mioni R

2004

Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients.

15293888

Kocak M

2004

Serum levels of prostate-specific antigen and androgens after nasal administration of a gonadotropin releasing hormone-agonist in hirsute women.

15295353

Dorn C

2004

Insulin enhances the transcription of luteinizing hormone-beta gene.

15302293

Hoeger KM

2004

A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.

15308691

Jansen E

2004

Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients.

15310006

Alper T

2004

Serum leptin and body composition in polycystic ovarian syndrome.

15314890

Hoyt KL

2004

Polycystic ovary (Stein-Leventhal) syndrome: etiology, complications, and treatment.

15315595

Douchi T

2004

Body fat patterning in polycystic ovary syndrome women as a predictor of the response to clomiphene.

15317431

Stoesser K

2004

Treatment of polycystic ovary syndrome in adolescents.